Biohit Oyj Stock Exchange Release
June 12, 2014at 10:40 a.m. (EEST)A total number of 160,000 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 ja II 2013 during May 21– June 2, 2014. These shares have been entered into the trade register on June 12, 2014, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading is expected to begin on NASDAQ OMX Helsinki as of June 13, 2014together with the existing B-shares. The share subscription price was EUR 2.2766per share with stock options I 2013 and II 2013. The entire subscription price of EUR 364,256will be credited to the reserve for invested non-restricted equity, and the company share capital remains unchanged. The shares have no nominal value. After the subscription the number of all Biohit Oyj'sshares will rise into 13,985,593 shares (13,825,593) and B-shares will rise into 11,010,093 shares (10,850,093). The new shares will correspond to a percentage of 1.1% of Biohit Oyj'stotal number of shares and 0.23% of the voting rights after registration. The share subscription period with stock options I 2013A began on June 1, 2014and all the available 100,000 shares were subscribed. The share subscription period with stock options II 2013 began on July 1, 2013and will end June 30, 2015. The option schemes are based on the Biohit Oyjboard resolution of June 19, 2013and the Annual General Meeting authorization of April 13, 2011. The terms and conditions of the option schemes with additional information are available on Biohit Oyjwebsite at www.biohithealthcare.com. Additional information: CEO Semi Korpela, Biohit Oyjtel. +358 9 773 861 email@example.com Biohitin brief Biohit Oyjis a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohitis headquartered in Helsinki, Finland, and has subsidiaries in Italyand the UK. Biohit'sSeries B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com Copyright © 2014 OMX AB (publ).